Role of sICAM-1 and sVCAM-1 as biomarkers in early and late stages of schizophrenia
详细信息 查看全文
- 作者：Maja Pantović Stefanovića ; majapantovic@yahoo.it" class="auth_mail" title="E-mail the corresponding author ; Nata&scaron ; a Petronijevićb ; c ; Bojana Dunjić-Kostića ; Milica Velimirovićb ; c ; Tatjana Nikolićb ; c ; Vladimir Juri&scaron ; ićd ; Maja Lačkovića ; b ; Aleksandar Damjanovića ; b ; Sanja Totić-Poznanovića ; b ; Aleksandar A. Jovanovića ; b ; Maja Ivkovića ; b
- 关键词：Clinical stage ; Schizophrenia ; Soluble intercellular adhesion molecule-1 ; Soluble vascular cell adhesion molecule-1 ; Antipsychotic treatment
- 刊名：Journal of Psychiatric Research
- 出版年：2016
- 出版时间：February 2016
- 年：2016
- 卷：73
- 期：Complete
- 页码：45-52
- 全文大小：590 K
文摘
- •
sICAM-1 levels in the early stage of SZ were comparable to healthy controls.
- •
sICAM-1 levels were elevated in the late stage of SZ compared to healthy controls.
- •
sVCAM-1 levels were decreased in both stages of SZ compared to healthy controls.
- •
sICAM-1 was related to the severity and type of symptoms in the early stage of SZ.
- •
Lower sICAM-1 was related to favorable treatment application in both stages of SZ.